Autoimmune

Immunology·MeSH: Autoimmune Diseases of the Nervous System

Prevalence

30.0 / 100K

86 drugs in development·56 companies·2 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
autoimmune analyzer	Quest Diagnostics Incorporated (DGX)
Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
Purified Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)

Phase 3(13)

Drug	Company
bexobrutideg	Nurix Therapeutics, Inc. (NRIX)
hmpl-523	HUTCHMED (China) Limited (HCM)
molbreevi	Savara Inc (SVRA)
molgramostim	Savara Inc (SVRA)
Molgramostim	Filana Therapeutics Inc. (FLNA)
molgramostim inhalation	Savara Inc (SVRA)
molgramostim nebulizer	Savara Inc (SVRA)
molgramostim open-label	Savara Inc (SVRA)
Obexelimab	Xencor Inc (XNCR)
parsaclisinib	Incyte Corp. (INCY)
rilzabrutinib sar444671	Sanofi (SNY)
Satralizumab	Crinetics Pharmaceuticals, Inc. (CRNX)
VAY736	Novartis AG (NVS)

Phase 2(9)

Drug	Company
IGM-2644	IGM Biosciences, Inc. (IGMS)
imvotamab	IGM Biosciences, Inc. (IGMS)
inebilizumab	AMGEN INC (AMGN)
isomyosamine	Q/C TECHNOLOGIES, INC. (QCLS)
kio-101	Kiora Pharmaceuticals Inc. (KPRX)
obexelimab	Zenas BioPharma, Inc. (ZBIO)
PRV-3279	MACROGENICS INC (MGNX)
sar445088	Sanofi (SNY)
zetomipzomib	Kezar Life Sciences, Inc. (KZR)

Phase 1(24)

Drug	Company
ANB101	ANAPTYSBIO, INC (ANAB)
ANX1502	Annexon, Inc. (ANNX)
AUR200	Aurinia Pharmaceuticals Inc. (AUPH)
Azer-cel	TG THERAPEUTICS, INC. (TGTX)
Azercabtagene zapreleucel	TG THERAPEUTICS, INC. (TGTX)
bivv020	Sanofi (SNY)
bms-986515	Juno Therapeutics, Inc. (JUNO)
cd19 hd allo car t	Editas Medicine, Inc. (EDIT)
CTX112	CRISPR Therapeutics AG (CRSP)
fludarabine	Juno Therapeutics, Inc. (JUNO)
frtx-02	Fresh Tracks Therapeutics, Inc. (FRTX)
ft839	FATE THERAPEUTICS INC (FATE)
KYV-101	Filana Therapeutics Inc. (FLNA)
LCAR-AIO T cells	Legend Biotech Corp (LEGN)
LUCAR-DKS1 NK cells	Legend Biotech Corp (LEGN)
LUCAR-G79 T cells	Legend Biotech Corp (LEGN)
m230	MOMENTA PHARMACEUTICALS INC (MNTA)
mb-106	MUSTANG BIO, INC. (MBIO)
rilzabrutinib amorphous form	Sanofi (SNY)
rilzabrutinib crystalline form	Sanofi (SNY)
tocilizumab	Juno Therapeutics, Inc. (JUNO)
vay736	Novartis AG (NVS)
velinotamig	Cullinan Therapeutics, Inc. (CGEM)
vib7734	Viela Bio, Inc. (VIE)

Preclinical(31)

Drug	Company
a2a agonists	REBUS HOLDINGS, INC. (NSPX)
adi-100	Aditxt, Inc. (ADTX)
AZD1656	CDT Equity Inc. (CDT)
AZD5658	CDT Equity Inc. (CDT)
crebankitug	Zura Bio Ltd (ZURA)
CUE-401	Cue Biopharma, Inc. (CUE)
CUE-501	Cue Biopharma, Inc. (CUE)
frtx-10	Fresh Tracks Therapeutics, Inc. (FRTX)
gtb-7550	GT Biopharma, Inc. (GTBP)
il-2 ai synthorin	Synthorx, Inc. (THOR)
inb-600	IN8BIO, INC. (INAB)
inb-619	IN8BIO, INC. (INAB)
jkb-122	Biostax Corp. (BTAX)
kros 102	Kairos Pharma, LTD. (KAPA)
KT-295	Kymera Therapeutics, Inc. (KYMR)
KYV-201	Intellia Therapeutics, Inc. (NTLA)
lnc-001	REBUS HOLDINGS, INC. (NSPX)
low dose naltrexone	Biostax Corp. (BTAX)
nm-102	9 METERS BIOPHARMA, INC. (NMTR)
phoenix auto	Phoenix Life Sciences International Limited. (PLSI)
prv-101	PROVENTION BIO, INC. (PBI)
pt001	Pandion Therapeutics, Inc. (PAND)
pt627	Pandion Therapeutics, Inc. (PAND)
repurposed drug for cns cancer	Cosmos Health Inc. (COSM)
sg293	Sana Biotechnology, Inc. (SANA)
sg299	Sana Biotechnology, Inc. (SANA)
small molecule nr2f6 modulators	Regen BioPharma Inc (RGBPP)
torudokimab	Zura Bio Ltd (ZURA)
vadc45	Vor Biopharma Inc. (VOR)
vib1116	Viela Bio, Inc. (VIE)
vx5	VACCINEX, INC. (VCNX)

Unknown(1)

Drug	Company
AZD1656 Cocrystal	CDT Equity Inc. (CDT)

Early Phase 1(1)

Drug	Company
JANX011	Janux Therapeutics, Inc. (JANX)

Phase 1/Phase 2(3)

Drug	Company
alpn-303	ALPINE IMMUNE SCIENCES, INC. (ALPN)
XmAb564	Xencor Inc (XNCR)
zugo-cel	CRISPR Therapeutics AG (CRSP)

BioSniper tracks 86 drugs in development for Autoimmune across 56 companies.

There are 2 clinical trials targeting Autoimmune tracked by BioSniper.

The estimated prevalence of Autoimmune is approximately 30.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.